Market-moving alerts received by Uptrends.ai subscribers this past week. Get alerts like these in real-time by subscribing to Uptrends premium here.

1. Pinduoduo (PDD)

PDD Investor Alert: Class Action Lawsuit and Stock Price Impact

Alert Summary: Temu parent company PDD faced a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, leading to a drop in the price of PDD ADSs. Investors who purchased PDD securities during the Class Period are encouraged to seek lead plaintiff appointment by October 15, 2024, due to potential damages incurred. The company's stock price was negatively impacted by reports of data privacy concerns and malware issues, affecting investors.

🔴 Alert Sentiment: Bearish

🚨 7D Alert Price Change: -31% ▼

2. Zoom Inc (ZM)

ZM Launches Single-Use Webinar Product, Share Repurchase Program

Summary: Zoom stock has rallied more than 18% in the past week. The stock price jumped after the company announced its second-quarter results, beating consensus estimates of revenues and earnings, and announcing plans to diversify its product portfolio with the launch of a new single-use webinar offering capable of hosting up to 1-million attendees. Additionally, its board of directors authorized a share repurchase program of up to $1.5 billion of common stock.

🟢 Alert Sentiment: Bullish

🚨 7D Alert Price Change: +18% ▲

3. Snowflake (SNOW)

SNOW Falls Below IPO Price Amid Growth Challenges

Summary: Snowflake (SNOW) has seen a decrease in growth rate since its IPO, with a stretched valuation. The company reported earnings revealing challenges from higher costs, competition, and macroeconomic conditions. CEO Frank Slootman's abrupt departure in February and Berkshire Hathaway's recent exit from the stock cast even more dark clouds over its future. Snowflake now trades slightly below its IPO price of $120.

🔴 Alert Sentiment: Bearish

🚨 7D Alert Price Change: -14% ▼

4. Fulcrum Therapeutics (FULC)

FULC: Surging Shares and Earnings Beat Streak

Summary: FULC, or Fulcrum Therapeutics, has consistently beaten earnings estimates in the last four quarters, with a four-quarter average earnings surprise of 393.18%. Year to date, shares of Fulcrum Therapeutics have surged 39.6%, and estimates for their 2024 loss per share have improved from $1.24 to 48 cents in the past 60 days, indicating positive growth potential for investors. The stock is now up more than 15% over the past 30 days.

🟢 Alert Sentiment: Bullish

🚨 7D Alert Price Change: +3% ▲

5. Advanced Auto Parts (AAP)

AAP Plummets: Weak Earnings and Slashed Outlook

Summary: AAP shares are trading lower by 4.62% to $48.74 after reporting weak second-quarter earnings and slashing FY24 outlook. Investors should look for signs that the company is focusing more effort on its retail automotive parts stores. Analysts have lowered price forecasts and the company's full-year guidance has been reduced, leading to a significant drop in stock value.

🔴 Alert Sentiment: Bearish

🚨 7D Alert Price Change: -20% ▼